CL

Business Profile & Competitive Position

Colgate-Palmolive Company operates in the Consumer Defensive sector under the Household & Personal Products industry. The company runs two reporting segments: Oral, Personal and Home Care (toothpaste, toothbrushes, soaps, deodorants, skin health products, household cleaners and fabric conditioners) and Hill’s Pet Nutrition (specialty dog and cat foods). It distributes products in more than 200 countries and territories through retailers, wholesalers, eCommerce platforms, veterinarians and certain direct-to-consumer channels.

The 2025 sales mix shows where revenue actually comes from: Oral Care contributed 44% of worldwide net sales, Personal Care 17%, Home Care 16% and Pet Nutrition 23%. That makes oral care the single largest profit pool and Hill’s the second-largest segment.

The profitability metrics are mixed. A net margin of 9.7% is consistent with a low-single-to-mid-digit-margin consumer staples business that has pricing power but also heavy marketing, supply-chain and input costs. The headline ROE of 631.1% is extraordinarily high and is best read as a capital-structure signal—very high leverage, a small equity base and/or substantial distributions can mathematically inflate ROE well beyond what operating returns alone would imply. It is not, by itself, proof of an unusually wide economic moat. The company’s beta of 0.32 does confirm low equity-market volatility, which aligns with the defensive, staple nature of the categories in which it competes.

Financial Posture

At a market capitalization of $69.5 billion and a trailing P/E of 34.1, Colgate-Palmolive is trading at a meaningful premium to many slower-growing staples names. That multiple suggests the market is pricing in reliable cash flows, brand durability and an above-average earnings growth trajectory relative to the broader household-products group.

The same capital-structure caveat applies to the 631.1% ROE: investors evaluating the business should pair that figure with balance-sheet and leverage metrics, because an ROE above 600% typically reflects a very thin equity cushion rather than pure operating outperformance. The 10-K notes management aims to use the balance sheet efficiently, which provides context for why leverage and capital-return policy are central to how returns on equity are generated.

The current trading snapshot shows the stock at $86.80, with an RSI of 33.4 and a 50-day EMA of $90.49. Price sits below the 50-day moving average, while RSI is approaching the lower end of the range that technicians often watch.

Strategic Priorities & Outlook

Colgate-Palmolive’s most recent 10-K lays out four operational priorities:

• Drive organic sales growth and deliver consistent, compounded earnings-per-share growth.
• Achieve operational efficiencies while growing free cash flow and using the balance sheet efficiently.
• Leverage global brand reach, science-based innovation, an agile supply chain and best-in-class omni-channel demand generation.
• Build capabilities in data, analytics and artificial intelligence and evolve a high-impact, inclusive culture.

The 2025 revenue breakdown and customer-concentration data provide the backdrop for those goals. Walmart and its affiliates represented approximately 11% of 2025 net sales—the only customer above the 10% disclosure threshold—while the company employed roughly 33,600 people in more than 100 countries, with over 84% located outside the United States. That geographic dispersion makes the “global brand reach” and “agile supply chain” priorities more than boilerplate; they are operational necessities given how widely the business is spread.

Macro & Geopolitical Exposure

As a Consumer Defensive household- and personal-products company, Colgate-Palmolive is generally exposed to stable, repeat-purchase demand rather than cyclical spending swings. Demand for toothpaste, soap, pet food and laundry products tends to hold up even when discretionary categories weaken.

That said, the industry carries predictable macro sensitivities. Raw-material and packaging costs (resins, surfactants, agricultural inputs for pet food, pulp and palm-oil derivatives), freight and energy prices all affect margins. Because the company operates in more than 200 countries and the vast majority of its workforce sits outside the U.S., foreign-exchange translation, cross-border tariffs and local regulatory regimes are constant variables. Retail consolidation is another sector-wide factor: one customer accounted for about 11% of 2025 sales, illustrating the influence large retailers can exert on pricing, shelf space and promotional terms. Packaging, labeling and ingredient regulations also matter in this industry, as do pet-food safety standards for the Hill’s business.

Recent Developments

• September 11, 2026 – Seeking Alpha: “Colgate-Palmolive Is Recovering Nicely (Rating Upgrade)” — the publication upgraded its rating on the stock.
• September 11, 2026 – 247wallst.com: “These 5 Dividend Stocks Survived 2008, COVID and Every Recession Before Them” — Colgate-Palmolive was included in a recession-resilient dividend-stock list.
• September 11, 2026 – Reuters: “Colgate-Palmolive seeks to divest some personal care brands, sources say” — the company is reportedly weighing divestitures in the personal-care portfolio.
• September 10, 2026 – Zacks: “EYE or CL: Which Is the Better Value Stock Right Now?” — a relative-value comparison naming Colgate-Palmolive.

Together, these headlines reflect two themes: analyst confidence appears to be improving, and management may be actively reshaping the brand portfolio through divestiture.

Earnings Behavior & Post-Earnings Drift

Colgate-Palmolive has beat earnings estimates in 8 out of the last 8 reported quarters, a 100% beat rate, with an average surprise of 3.3%. Over the five trading days following each of those reports, the stock has averaged a move of +2.32%, classified as an upward post-earnings drift.

The most recent four quarters illustrate the pattern:

• July 31, 2026: EPS $0.99 vs. $0.947 estimate (+4.5% surprise); the stock fell 1.56% the next day but rose 2.16% over the following five days.
• May 1, 2026: EPS $0.97 vs. $0.943 estimate (+2.9% surprise); the stock fell 2.17% the next day and gained 0.33% over the following five days.
• January 30, 2026: EPS $0.95 vs. $0.912 estimate (+4.2% surprise); the stock rose 1.77% the next day and 4.56% over the following five days.
• October 31, 2025: EPS $0.91 vs. $0.889 estimate (+2.4% surprise); the stock fell 2.69% the next day but climbed 2.22% over the following five days.

A few points stand out. First, beats have been reliable but modest—the largest surprise was 4.5%, not a blowout. Second, the next-day reaction has been negative in three of the last four reports, suggesting the market may already price in upside and treats in-line beats as a sell-the-news event. Third, five-session drift has been positive in three of the four quarters and on average, which implies that any initial disappointment has tended to fade as investors digest the underlying numbers.

The next report is scheduled for October 30, 2026, before the open, with a consensus EPS estimate of $0.92.

For a deeper dive into how sell-side and institutional models currently view Colgate-Palmolive—alongside valuation aggregates, consensus revisions and ownership trends—review the full institutional verdict on the ticker page.